Cadila Pharmaceuticals
Media
Media Coverages
Cadila Pharmaceuticals sets new standard...

EMedia/Digital Coverages

The Pharma TimesBiospectrum IndiaIndia Pharma Outlook
Indian Pharma PostIndia Med TodayHealth Vision
Divya Bhaskar (online)Business Gujarat

Print Coverages

downWhiteCurveArrow
footer-logo

Contact Us

contact-icon
+91 22 66220000
Contact Us
FacebookInstagramLinkedinXYoutube
Privacy PolicyADR ReportingDrug Counterfeiting

Corporate Identification No : U24231GJ1991PLC015132

©2026 Cadila Pharmaceuticals. All rights reserved

Cadila Pharmaceuticals sets new standard in migraine management with Vasograin Plus